PTEN mutations in uterine sarcomas

Gynecologic Oncology

Volumn 85, Issue 1, 2002, Pages 165-169

  Amant, F ^a,b   De la Rey, M ^c   Dorfling, C M ^c   Van der Walt, L ^c   Dreyer, G ^b   Dreyer, L ^c   Vergote, I ^a   Lindeque, B G ^b   Van Rensburg, E J ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b STEVE BIKO ACADEMIC HOSPITAL   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Carcinosarcoma; Leiomyosarcoma; PTEN mutation; Uterine sarcoma

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; CARCINOSARCOMA; CHROMOSOME 10Q; CONTROLLED STUDY; ENDOMETRIUM SARCOMA; EXON; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; METAPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; UTERUS SARCOMA;

EID: 0036225765     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6601     Document Type: Article

References (41)

1. Mesenchymal tumors of the uterus
2. Cytogenetic profile of uterine sarcomas
3. Chromosomal abnormalities in leiomyosarcomas
4. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma
5. Evidence for a common etiology for endometrial carcinomas and malignant mixed Mullerian tumors
6. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus
7. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: A Gynecological Oncology Group pathologic study of 203 cases
8. Carcinosarcomas of the female genital tract: A pathologic study of 29 metastatic tumors: Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis
9. The immunohistochemical profile of malignant mixed Müllerian tumor
10. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed mullerian turnouts
11. Carcinosarcomas (malignant mixed Mullerian tumors) of the female genital tract: Comparative molecular analysis of epithelial and mesenchymal components
12. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary
13. Characteristics of cloned cells of mixed Müllerian tumor of the human uterus
14. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
15. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies
16. PTEN/MMAC1 mutations in endometrial cancers
17. PTEN1 is frequently mutated in primary endometrial carcinomas
18. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
19. The multiple roles of PTEN in tumor suppression
20. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias
21. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma
22. Problematic uterine smooth muscle neoplasms: A clinicopathologic study of 213 cases
23. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas
24. PTEN, a putative protein tyrosinase phophatase gene mutated in human brain, breast and prostate cancer
25. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
26. Mutations of the human PTEN gene
27. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients
28. An update of HNPCC (Lynch syndrome)
29. Genetic instability of microsatellites in endometrial carcinoma
30. Microsatellite instability in endometrial carcinoma
31. Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with a germline MSH2 mutation
32. Microsatellite instability in uterine sarcomas
33. Mutational analysis of the PTEN gene in human uterine sarcomas
34. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis
35. PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases
36. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers
37. p53 alterations in uterine leiomyosarcomas versus leiomyomas
38. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas
39. t(10:17) as the sole chromosome change in a uterine leiomyosarcoma
40. Ins (10:19) in an endometrial stromal sarcoma
41. Recommendations for a nomenclature system for human gene mutations